33.54
0.00
(0.00%)
May 23 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | - |
| 52 week | 24.78 - 34.48 |
| Open | - |
| Vol / Avg. | 0.00/133,300.00 |
| Mkt cap | 951.64M |
| P/E | 23.44 |
| Div/yield | 0.15/1.79 |
| EPS | 1.43 |
| Shares | 28.37M |
| Beta | 1.16 |
| Inst. own | 94% |
Events
Jul 22, 2013
Q2 2013 CONMED Earnings Release
May 30, 2013
CONMED at Deutsche Bank dbAccess Health Care Conference
- 4:10PM EDT -
May 23, 2013
CONMED Annual Shareholder Meeting
May 22, 2013
CONMED at UBS Global Healthcare Conference -
May 16, 2013
CONMED at Bank of America Merrill Lynch Health Care Conference -
Apr 30, 2013
CONMED at Needham Healthcare Conference -
Apr 25, 2013
Q1 2013 CONMED Earnings Conference Call -
Apr 25, 2013
Q1 2013 CONMED Earnings Release
Mar 19, 2013
CONMED at Canaccord Genuity Musculoskeletal Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 5.61% | 5.28% |
| Operating margin | 8.35% | 8.50% |
| EBITD margin | - | 16.70% |
| Return on average assets | 3.89% | 4.01% |
| Return on average equity | 6.99% | 6.86% |
| Employees | 3,600 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's powered instruments product line includes the MPower battery system. The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.
Officers and directors
| Eugene R. Corasanti | Chairman of the Board, Vice Chairman | |
| Joseph J. Corasanti | President, Chief Executive Officer, Director | |
| Robert D. Shallish Jr. | Chief Financial Officer, Executive Vice President - Finance, Assistant Secretary | |
| Daniel S. Jonas | Executive Vice President - Legal Affairs, General Counsel | |
| Luke A. Pomilio | Executive Vice President, Corporate General Manager, Controller | |
| Heather L. Cohen | Executive Vice President - Human Resources, Deputy General Counsel, Secretary | |
| William W. Abraham | Executive Vice President - Business Development | |
| Joseph G. Darling | Executive Vice President - Corporate Commercial Operations | |
| Gregory Renard Jones | Executive Vice President - Quality Assurance/Regulatory Affairs | |
| Mark E. Tryniski | Lead Independent Director |